Discover our publications
Direct process reproduction from multi-layer bioreactor and roller bottles for four vaccine antigens using three different cell lines (CEF, WI-38 and Vero cells)
Learn more
Discover the integrated and automated NevoLine Upstream platform. Get insight on its design aligning flexibility and productivity with various process configurations according to your process needs. Get insights on case studies for vaccine and gene therapy production.
Visit site
Univercells Technologies provides reliable service solutions and quality support & maintenance to help you maintain performance and maximum safety of the equipment.
Download
The scale-X hydro bioreactor is a small-scale, single-use, structured fixed-bed bioreactor enabling direct process transfer from existing processing technology for rapid proof of concept within a reduced footprint.
Download
Case study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.
Learn more
The NevoLine™ Upstream system is a high-performance and automated platform for commercial virus manufacturing. It integrates all process steps from inoculation to midstream processing to deliver a ready for downstream bulk.
Download
Discover how Ology Biosciences is leveraging Univercells Technologies’ intensified fixed-bed bioreactor and bioprocessing expertise to bring vaccine production to the next level. Get case study results and expert insights on how to find success with adherent-cell growth profiles and viral performance to produce viral vaccines using the scale-X bioreactors.
Visit site
The scale-X™ bioreactor range and the NevoLine™ platform: integrated and automated solutions for an intensified AAV and Lentiviral vectors manufacturing.
Download
A case study on AAV and Adenovirus vectors presented at ASGCT 23rd Annual meeting 2020 by our Deputy CTO, Tania Pereira Chilima
DownloadPoster illustrates the key features, benefits and applications of the NevoLine concept with the emphasis on the first implementation of this approach – The NevoLine platform for trivalent polio vaccine (sIPV).
DownloadProof of concept for scalable adherent cell growth and adenovirus production
Learn more
The scale-X™ carbo system is a bench-scale automated cell culture system for expression and concentration of viral drug substance, suited for rapid process development and cost-effective clinical production.
DownloadThe NevoLine sIPV platform was designed and developed by Univercells as part of a $12M Grand Challenges grant awarded by the Bill & Melinda Gates Foundation. This proof of concept was developed to deliver affordable inactivated polio vaccine (sIPV) in a low footprint.
DownloadPoster presents the NevoLine concept to deliver affordable vaccine doses based on sIPV polio vaccine case study.
Download